Abstract:Insulin, a peptide hormone, is one of the most common and effective antidiabetic drugs. Although oral administration is considered to be the most convenient and safe choice for patients, the oral bioavailability of insulin is very low due to the poor oral absorption into blood circulation. Intestinal epithelium is a major barrier for the oral absorption of insulin. Therefore, it is vital to develop intestinal permeation enhancer to increase the antidiabetic efficacy of insulin after oral administration.Methods: Charge-switchable zwitterionic polycarboxybetaine (PCB) was used to load insulin to form PCB/insulin (PCB/INS) particles through the electrostatic interaction between positively charged PCB in pH 5.0 and negatively charged insulin in 0.01 M NaOH. The opening effect of PCB/INS particles on intestinal epithelium was evaluated by detecting the changes of claudin-4 (CLDN4) protein and transepithelial electrical resistance (TEER) after incubation or removal. The mechanism was further elucidated based on the results of Western blot and fluorescence images. The PCB/INS particles were then used for type 1 diabetes mellitus therapy after oral administration.Results: PCB could load insulin with the loading efficiency above 86% at weight ratio of 8:1. PCB/INS particles achieved sustained release of insulin at pH 7.4 due to their charge-switchable ability. Surprisingly, PCB/INS particles induced the open of the tight junctions of intestinal epithelium in endocytosis-mediated lysosomal degradation pathway, which resulted in increased intestinal permeability of insulin. Additionally, the opening effect of PCB/INS particles was reversible, and the decreased expression of CLDN4 protein and TEER values were gradually recovered after particles removal. In streptozotocin-induced type 1 diabetic rats, oral administration of PCB/INS particles with diameter sub-200 nm, especially in capsules, significantly enhanced the bioavailability of insulin and achieved longer duration of hypoglycemic effect than the subcutaneously injected insulin. Importantly, there was no endotoxin and pathological change during treatment, indicating that PCB/INS particles were safe enough for in vivo application.Conclusion: These findings indicate that this system can provide a platform for oral insulin and other protein drugs delivery.

Crosslinked zwitterionic microcapsules to overcome gastrointestinal barriers for oral insulin delivery

Preparation of chitosan-based multifunctional nanocarriers overcoming multiple barriers for oral delivery of insulin.

Enhanced Oral Delivery of Insulin Via Loading in Polysorbate-80 Micelles

Dually-crosslinked Degradable Polyionic Micelles for Sustained Glucose-responsive Insulin Release

Zwitterionic micelles efficiently deliver oral insulin without opening tight junctions

Ph- and Amylase-Responsive Carboxymethyl Starch/Poly(2-isobutyl-acrylic Acid) Hybrid Microgels As Effective Enteric Carriers for Oral Insulin Delivery

A nano-delivery system based on preventing degradation and promoting absorption to improve the oral bioavailability of insulin

Goblet Cell Targeting Nanoparticle Containing Drug-Loaded Micelle Cores for Oral Delivery of Insulin.

Ursodeoxycholic Acid-Decorated Zwitterionic Nanoparticles for Orally Liver-Targeted Close-Looped Insulin Delivery.

Overcoming Oral Insulin Delivery Barriers: Application of Cell Penetrating Peptide and Silica-Based Nanoporous Composites

Overcoming Multiple Absorption Barrier for Insulin Oral Delivery Using Multifunctional Nanoparticles Based on Chitosan Derivatives and Hyaluronic Acid

Dual Stimuli-Responsive Nanoparticle-Incorporated Hydrogels As an Oral Insulin Carrier for Intestine-Targeted Delivery and Enhanced Paracellular Permeation.

Oral Insulin Delivery by Carboxymethyl-Β-cyclodextrin-grafted Chitosan Nanoparticles for Improving Diabetic Treatment.

Charge-switchable zwitterionic polycarboxybetaine particle as an intestinal permeation enhancer for efficient oral insulin delivery

Enhancing Insulin Oral Absorption by Using Mucoadhesive Nanoparticles Loaded with LMWP-linked Insulin Conjugates.

Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin

Ph-Sensitive O-carboxymethyl Chitosan/sodium Alginate Nanohydrogel for Enhanced Oral Delivery of Insulin.

N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption

Construction and functional evaluation of oral long-acting insulin hydrogel microparticles based on physical and chemical double crosslinking

Oral Delivery of Berberine by Liver-Targeted Zwitterionic Nanoparticles to Overcome Multi-Intestinal Barriers and Extend Insulin Treatment Duration

β-Cyclodextrin/dialdehyde glucan-coated keratin nanoparticles for oral delivery of insulin